genenta.com (GNTA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

The dynamics of consensus EPS forecasts for the coming year demonstrate that the indicator stands at 0.00. The Genenta Science S.p.A. (GNTA) business is completely decoupled from economic cycles, as success is based on molecule trials. The Italian innovator possesses high scientific authority in gene therapy. However, asset valuation relies critically on R&D pipeline results and the rate of capital burn before reaching stable revenue.

Genenta Science S.p.A. (GNTA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 04.11.2026

Ringkesan rincian data analitis Genenta Science SpA (GNTA)

- rega saham lan konsensus proyeksi valuasi:

Rega saham Genenta Science SpA|GNTA - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Nilai pasar Genenta Science SpA|GNTA - Nilai Total Perusahaan

- rincian nilai buku perusahaan:

Aset Bersih saben Siji Saham Genenta Science|GNTA - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih genenta.com|GNTA - Nilai Agregat Aset

- informasi babagan utang lan solvabilitas:

Total Utang marang Modal Genenta Science S.p.A.|GNTA - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Genenta Science SpA|GNTA - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Genenta Science S.p.A.|GNTA - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Genenta Science|Indikator likuiditas cepet genenta.com

- data bathi resik lan rasio valuasi:

GNTA - Bathi pungkasan|Bathi mangsa ngarep Genenta Science S.p.A.|GNTA - Rasio rega pasar marang bathi resik|Pangali Forward P/E genenta.com|GNTA - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Genenta Science|GNTA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Genenta Science|GNTA - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan genenta.com|GNTA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Genenta Science S.p.A.

- statistik dodolan lan pendapatan perusahaan:

GNTA - Pendapatan tahunan perusahaan|Volume dodolan mangsa ngarep perusahaan Genenta Science SpA|GNTA - Rega marang dodolan|Multiplikator Forward P/S Genenta Science SpA

Analisis fundamental perusahaan:GNTA, Genenta

This indicator measures analysts' average expectations for changes in earnings per share, reflecting the sensitivity of the market valuation to future financial results. The trend in consensus EPS forecasts for the coming year demonstrates how the implementation of innovative gene therapy for solid tumors impacts the potential capitalization of Genenta Science S.p.A. (GNTA). Steady growth in this metric confirms the high commercial value of targeted interferon delivery and the overall resilience of the business model.

Perusahaan pesaing